fda warning on semaglutide alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products The FDA and the maker

Why did I get a text message from CenterWell Pharmacy or CoAssist Pharmacy

Key wegovy side effects include: Gastrointestinal issues (nausea, vomiting, diarrhea, constipation) Headaches and dizziness Hypoglycemia (especially in patients with type 2 diabetes) Increased heart rate Pancreatitis Thyroid C-cell tumors (in animal studies) Its imperative for individuals to closely monitor their health and report any adverse reactions to their healthcare provider to manage and mitigate potential risks effectively

Oral pills approved by the FDA in early 2026 are showing strong effectiveness

Psychosocial stress and overweight and obesity: findings from the Chicago Community Adult Health Study

Semaglutide is a single-pathway GLP-1 receptor agonist, while tirzepatide is a dual GLP-1/GIP receptor agonist that activates two incretin receptors at once